top of page
Dofetilide

多非利特
Mechanism of action:
Dofetilide 是一種選擇性鉀離子通道阻斷劑(selective potassium channel blocker)。Dofetilide 高度選擇性抑制 hERG 鉀離子通道(human ether-à-go-go-related potassium channel),此通道負責心臟再極化(repolarization)過程中的延遲整流鉀電流(IKr,rapid delayed rectifier potassium current)。當 IKr 受到 dofetilide 抑制時,會使心肌再極化延遲,導致動作電位持續時間與 QT 間期延長。
Reference(s):
1. Lenz TL et al. (2000). Dofetilide, a new class III antiarrhythmic agent. Pharmacotherapy.
2. Lenz TL et al. (2000). Dofetilide: A new antiarrhythmic agent approved for conversion and/or maintenance of atrial fibrillation/atrial flutter. Drugs Today (Barc).
bottom of page
